On Friday, Shares of Merck & Co., Inc. (NYSE:MRK), subtract -0.59% and closed at $62.14 in the last trading session. The last trading range of the stock ranges between $62.13 and $62.86. Merck (MRK), known as MSD outside the United States and Canada, recently declared the launch of Biosimilars Clarified a new educational website for patients, caregivers and the healthcare community that is designed to provide clear, concise and straightforward information about biosimilar medicines.
Biosimilars are a type of biological product that are approved by the U.S. Food and Drug Administration (FDA) because they are highly similar to an already FDA-approved biological product, known as the originator biologic or reference product, and have been shown to have no clinically meaningful differences in terms of the safety, purity and potency of the product.
“Biosimilars can offer alternative treatment options, and have the potential to assist reduce healthcare spending and increase access to important biologic medicines,” said Dora Bibila, general manager, Merck Biosimilars. “At Merck, we want to provide educational resources for patients and caregivers to assist them get the information they want and need. We believe the more patients know, the more they can be in charge of their health – Biosimilars Clarified is designed to assist answer their questions about biosimilars.”
Applied Materials, Inc. (NASDAQ:AMAT), jumped 0.75% and closed at $28.07 in the last trading session. The last trading range of the stock ranges between $27.82 and $28.41. The company’s Market capitalization is $30.57 Billion with the total Outstanding Shares of 1.08 billion. Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, display, solar photovoltaic (PV), and related industries worldwide. It operates through four segments: Silicon Systems, Applied Global Services, Display, and Energy and Environmental Solutions. The Silicon Systems segment develops, manufactures, and sells a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits. Its products and technologies for transistor and interconnect fabrication, counting epitaxy, ion implantation, oxidation and nitridation, rapid thermal processing, chemical vapor deposition, physical vapor deposition, chemical mechanical planarization, electrochemical deposition, atomic layer deposition, etch, and metrology and inspection, in addition to systems that facilitates transfer of patterns used in the photolithography. The Applied Global Services segment provides solutions to enhance the performance and productivity of semiconductor, display, and solar products. The Display segment offers products for manufacturing liquid crystal displays, organic light-emitting diodes, and other display technologies for televisions, personal computers, tablets, smartphones, and other consumer-oriented devices.
Delta Air Lines, Inc. (NYSE:DAL), jumped 0.07% and closed at $40.04 in the last trading session. The last trading range of the stock ranges between $39.82 and $40.75. The company’s Market capitalization is $30.01 Billion with the total Outstanding Shares of 736.38 million. During the 52-week trading session the minimum price at which share price traded, registered at $32.60 and reached to max level of $52.77. United Continental Holdings Inc., longtime laggard of U.S. airlines, is up 41 percent since late June as shareholders buy into the troubled carrier’s promise of an imminent turnaround. United’s new president, Scott Kirby, an airline industry star — plucked soon after he parted ways with American Airlines Group Inc. in late August — will join a conference call Tuesday, after the carrier reports earnings late Monday. Now the question everyone wants answered is whether Kirby, who has a proven knack for turning around airlines, can assist revive United and start filling its coffers anew. “When are they going to produce?” asked Jim Jackson, a former airline consultant who owns about a thousand United shares, voicing a common refrain among shareholders.source bloomberg